Sezary Syndrome Pipeline Insights 2024, Featuring Major Players 4SC, Seagen, Merck Sharp & Dohme, Innate Pharma, Trillium Therapeutics and Secura Bio
April 15, 2024 10:07 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Sezary Syndrome - Pipeline Insights, 2024" has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights about 5+...